Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Vera Therapeutics, Inc.
Market Cap
$2.11B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.11B
Gross Margin
32.36%
TTM Avg
32.47%
3Y Avg
32.14%
5Y Avg
31.56%
Market Cap
$2.11B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
22.50%
5Y Avg
47.90%
Market Cap
$2.13B
Gross Margin
68.20%
TTM Avg
66.69%
3Y Avg
41.60%
5Y Avg
26.81%
Market Cap
$2.06B
Gross Margin
99.55%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
-349.27%
Market Cap
$2.06B
Gross Margin
100.00%
TTM Avg
-1064.88%
3Y Avg
-1783.56%
5Y Avg
-1442.31%
Market Cap
$2.17B
Gross Margin
17.98%
TTM Avg
29.88%
3Y Avg
47.29%
5Y Avg
57.26%
Market Cap
$2.05B
Gross Margin
74.56%
TTM Avg
73.48%
3Y Avg
70.60%
5Y Avg
69.69%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | $2.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 32.36% | 32.47% | 32.14% | 31.56% |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 0.00% | 0.00% | 22.50% | 47.90% |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | 68.20% | 66.69% | 41.60% | 26.81% |
| Alvotech (ALVO)vs › | $2.08B | 60.45% | 60.99% | 17.21% | 44.81% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | 99.55% | 100.00% | 100.00% | -349.27% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 100.00% | -1064.88% | -1783.56% | -1442.31% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 17.98% | 29.88% | 47.29% | 57.26% |
| Vericel Corporation (VCEL)vs › | $2.05B | 74.56% | 73.48% | 70.60% | 69.69% |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
